Astera Labs (NASDAQ:ALAB) Posts Earnings Results, Beats Expectations By $0.13 EPS

Posted by Brenda Bartman on Nov 5th, 2026

Astera Labs (NASDAQ:ALAB – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.13, FiscalAI reports. The firm had revenue of $584.90 million during the quarter, compared to the consensus estimate of $550.78 million. Astera Labs had a net margin of 29.64% and a return on equity of 27.30%. The firm’s quarterly revenue was up 153.6% on a year-over-year basis. During the same period last year, the firm posted $0.49 EPS.

Here are the key takeaways from Astera Labs’ conference call:

Record Q3 performance: Revenue reached $584.9 million, up 49% sequentially and 154% year over year, while non-GAAP operating margin expanded to 44.7% and EPS rose 65% sequentially to $1.32.
Strong near-term outlook: Astera guided for Q4 revenue of $730 million to $750 million, representing 27% sequential growth at the midpoint, driven by continued Scorpio X-Series and P-Series expansion and growing Aries and Taurus demand.
Scorpio momentum broadened: Scorpio became the company’s largest product family, with annualized revenue exceeding $1 billion; management cited new customer ramps, additional platforms, and continued growth opportunities into 2027.
New growth vectors are progressing: Optical connectivity, Leo memory controllers, custom silicon, and Orion rack-scale platforms are expanding Astera’s addressable market, although most are expected to contribute meaningful revenue beginning in late 2027 or 2028.
Investment and execution remain key risks: Q4 operating expenses are expected to rise to $194 million–$200 million as the company funds new initiatives, while several opportunities—including UALink, optical products, custom solutions, and Orion—remain dependent on customer qualification and future platform ramps.

Astera Labs Price Performance

ALAB traded down $30.73 during trading on Thursday, reaching $192.54. The company had a trading volume of 1,131,147 shares, compared to its average volume of 5,090,759. Astera Labs has a 12 month low of $97.89 and a 12 month high of $499.48. The business’s fifty day moving average price is $304.94 and its 200 day moving average price is $255.78. The company has a market cap of $33.40 billion, a P/E ratio of 77.47 and a beta of 3.85.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

Positive Sentiment: BMO Capital Markets initiated coverage with an Outperform rating and a $375 price target. Northland Securities also upgraded the stock to Outperform, with a $315 target. BMO Capital Markets rating Northland Securities rating
Positive Sentiment: Q3 results beat expectations: adjusted EPS was $1.32 versus $1.19 estimated, while revenue reached $584.9 million, up 153.6% year over year. Scorpio X-Series switches drove growth, and management forecast Q4 revenue of $730 million to $750 million. Q3 results and Scorpio growth
Neutral Sentiment: Analyst views remain mixed: Morgan Stanley raised its target to $389 and RBC maintained Outperform while cutting its target to $400; Susquehanna lowered its target to $258 and kept a Neutral rating. Morgan Stanley rating
Negative Sentiment: Shares have fallen amid concerns that the valuation remains rich, even after the earnings beat. Reports also point to analysts trimming forecasts, rising costs, competition and customer concentration as risks; TD Cowen cut its target to $225 and assigned a Hold rating. Valuation concerns after Q3 Analyst forecast changes

Wall Street Analyst Weigh In

Several research firms have recently weighed in on ALAB. Roth Capital reaffirmed a “buy” rating and set a $450.00 price objective on shares of Astera Labs in a report on Wednesday, August 5th. Royal Bank Of Canada reduced their target price on Astera Labs from $500.00 to $400.00 and set an “outperform” rating on the stock in a report on Wednesday. UBS Group decreased their price target on Astera Labs from $300.00 to $290.00 and set a “neutral” rating on the stock in a research report on Wednesday. Northland Securities upgraded Astera Labs from a “market perform” rating to an “outperform” rating and set a $315.00 price target on the stock in a research report on Wednesday. Finally, TD Cowen dropped their price target on Astera Labs from $300.00 to $225.00 and set a “hold” rating for the company in a report on Wednesday. Thirteen analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $320.85.

Read Our Latest Stock Analysis on Astera Labs

Insider Activity at Astera Labs

In related news, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total value of $51,263,790.00. Following the sale, the director directly owned 253,863 shares of the company’s stock, valued at approximately $71,114,642.19. The trade was a 41.89% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the company’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the transaction, the chief executive officer directly owned 1,266,665 shares of the company’s stock, valued at approximately $431,109,432.75. The trade was a 6.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 396,059 shares of company stock valued at $123,408,470 over the last three months. Insiders own 10.40% of the company’s stock.

About Astera Labs

(Get Free Report)

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.